Funding Round Overview

Isomorphic Labs announced a Series A round on January 15, 2025 totaling $600,000,000 led by Alphabet. DeepMind spinoff Isomorphic Labs raised $600 million to build AI Science Factories. $600M for AI drug discovery.

Deal Highlights

• Capital involved: $600,000,000.
• Round: Series A.
• Investors: Alphabet, Temasek, Sequoia.

Company and Sector Context

Isomorphic Labs builds in the healthcare ai sector, one of the most active areas in AI investment today. Based in United Kingdom, the company is part of a global wave of startups scaling AI into production across regulated and enterprise environments.

How the Capital Helps

Disclosed details include $600M for AI drug discovery. In healthcare ai, speed to market and access to high-quality talent often determine category leadership.

Competitive Landscape

Funding activity in healthcare ai continues to intensify as incumbents and startups race to ship reliable AI systems. This round signals ongoing investor confidence in differentiated technology and defensible distribution.

Looking Ahead

This funding positions Isomorphic Labs for continued growth in the healthcare ai landscape. As AI adoption accelerates across industries, deals like this signal where capital and strategic attention are moving next.